麻豆传媒

Labels highlighting the risk of cancer can shift behavior

Drug is approved in combination with fludarabine

Glatiramer acetate gets new boxed warning

The freeze is expected to last until the end of the month

Over $1 billion of funding has so far failed to bring any new therapies to market

Health news and commentary gathered by 麻豆传媒 staff

Nasal spray now approved as monotherapy for treatment-resistant depression

Some members of Trump's inner circle are gearing up to battle "Big Food"

In trial, datopotamab deruxtecan increased progression-free survival by 2 months

And 40.5% noted efficacy claims not listed on the labels of their originator products

While niche for now, use of flavored nicotine sachets among youths raises concerns

Three drug approvals in a sample of 24 deviated from others

Estimates suggest millions of deaths would be averted within the century

Consumer advocates praised the decision